Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Vaxxinity, Inc. (VAXX : NSDQ)
 
 • Company Description   
Vaxxinity Inc. is a biotechnology company pioneering a new class of immunotherapeutic vaccines to democratize health. Vaxxinity Inc. is based in DALLAS, Texas.

Number of Employees: 89

 
 • Price / Volume Information   
Yesterday's Closing Price: $4.45 Daily Weekly Monthly
20 Day Moving Average: 2,599,066 shares
Shares Outstanding: 125.84 (millions)
Market Capitalization: $559.99 (millions)
Beta:
52 Week High: $22.77
52 Week Low: $3.04
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 33.63% 46.43%
12 Week -16.35% -9.24%
Year To Date -20.68% -5.67%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1717 MAIN STREET SUITE 3388
-
DALLAS,TX 75201
USA
ph: 254-244-5739
fax: -
ir@vaxxinity.com http://www.vaxxinity.com
 
 • General Corporate Information   
Officers
Mei Mei Hu - Chief Executive Officer; President and Director
Jason Pesile - Senior Vice President; Finance & Accounting
Louis Reese - Director
George Hornig - Director
Greg Blatt - Director

Peer Information
Vaxxinity, Inc. (CORR.)
Vaxxinity, Inc. (RSPI)
Vaxxinity, Inc. (CGXP)
Vaxxinity, Inc. (BGEN)
Vaxxinity, Inc. (GTBP)
Vaxxinity, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 92244V104
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/08/22
Share - Related Items
Shares Outstanding: 125.84
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $559.99 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.40 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.38 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/08/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 4.97
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 35.42%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -85.46
12/31/21 - -124.03
09/30/21 - -
Current Ratio
03/31/22 - 5.46
12/31/21 - 5.61
09/30/21 - 3.39
Quick Ratio
03/31/22 - 5.46
12/31/21 - 5.61
09/30/21 - 3.39
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -184,204.48
12/31/21 - -207,840.92
09/30/21 - -
Book Value
03/31/22 - 0.90
12/31/21 - 1.03
09/30/21 - -
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.09
12/31/21 - 0.08
09/30/21 - -
Debt-to-Capital
03/31/22 - 8.32
12/31/21 - 7.43
09/30/21 - -
 

Powered by Zacks Investment Research ©